PD Dr. Anita Kremer



Organisation


Medizinische Klinik 5 - Hämatologie und Internistische Onkologie


Publications (Download BibTeX)


Kretschmann, S., Herda, S., Bruns, H., Russ, J., van der Meijden, E.D., Schlötzer-Schrehardt, U.,... Kremer, A. (2019). Chaperone protein HSC70 regulates intercellular transfer of Y chromosome antigen DBY. Journal of Clinical Investigation, 130. https://dx.doi.org/10.1172/JCI123105
Bernhardt, A.L., Kretschmann, S., Bausenwein, J., Balzer, H., Mackensen, A., & Kremer, A. (2018). Characterizing the Immunogenicity of DM-Sensitive and DM-Resistant Antigens. In BLOOD. San Diego, CA, US: WASHINGTON: AMER SOC HEMATOLOGY.
Kremer, A., Zonneveld, M.I., Kremer, A.E., Van Der Meijden, E.D., Falkenburg, J.H.F., Wauben, M.H.M.,... Griffioen, M. (2018). Natural T-cell ligands that are created by genetic variants can be transferred between cells by extracellular vesicles. European Journal of Immunology. https://dx.doi.org/10.1002/eji.201747152
Würfel, F., Erber, R., Hübner, H., Hein, A., Lux, M.P., Jud, S.,... Rübner, M. (2018). TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes. Breast Care, 13(1), 8-14.
Erber, R., Hartmann, A., Beckmann, M., Mackensen, A., Kremer, A., Reimann, H.,... Fasching, P. (2018). TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes. Pathologe, 39(Suppl 2), 236-240. https://dx.doi.org/10.1007/s00292-018-0526-7
Voelkl, S., Rensing-Ehl, A., Allgäuer, A., Schreiner, E., Lorenz, M.R., Rohr, J.,... Mackensen, A. (2016). Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome. Blood, 128(2), 227-38. https://dx.doi.org/10.1182/blood-2015-11-685024
Pont, M.J., Honders, M.W., Kremer, A., Van Kooten, C., Out, C., Hiemstra, P.S.,... Griffioen, M. (2016). Microarray Gene Expression Analysis to Evaluate Cell Type Specific Expression of Targets Relevant for Immunotherapy of Hematological Malignancies. PLoS ONE, 11(5), e0155165. https://dx.doi.org/10.1371/journal.pone.0155165
Aigner, M., Bruns, H., Gary, R., Jitschin, R., Kremer, A., Mougiakakos, D.,... Gerbitz, A. (2014). Advances in cellular therapy: 7th international symposium on the clinical use of cellular products, March 14 and 15, 2013, Erlangen, Germany. Cancer Immunology Immunotherapy, 63(2), 185-93. https://dx.doi.org/10.1007/s00262-013-1498-3
Kremer, A., Van Der Griendt, J.C., Van Der Meijden, E.D., Honders, M.W., Ayoglu, B., Schwenk, J.M.,... Griffioen, M. (2014). Development of a coordinated allo T cell and auto B cell response against autosomal PTK2B after allogeneic hematopoietic stem cell transplantation. Haematologica, 99(2), 365-9. https://dx.doi.org/10.3324/haematol.2013.086652
Kremer, A., Van Der Meijden, E.D., Honders, M.W., Pont, M.J., Goeman, J.J., Falkenburg, J.H.F., & Griffioen, M. (2014). Human leukocyte antigen-DO regulates surface presentation of human leukocyte antigen class II-restricted antigens on B cell malignancies. Biology of Blood and Marrow Transplantation, 20(5), 742-7. https://dx.doi.org/10.1016/j.bbmt.2014.02.005

Last updated on 2017-08-02 at 04:09